Changes in glomerular filtration rate and effective renal plasma flow following a protein meal were measured in seven patients with esssential hypertension on no treatment and after 6 weeks' treatment with nifedipine and mefruside. Glomerular filtration rate and effective renal plasma flow increased significantly following a protein meal in patients on no treatment (P<O.O1 and P<0.05 respectively). The response to a protein meal was lost following antihypertensive treatment (P<0.5 and P<0.1 respectively). Although there was some increase in the fasting values of glomerular filtration rate and effective renal plasma flow this was less pronounced and more difficult to demonstrate when only fasting values were compared. We propose that the loss of response to a protein meal is due to recruitment of renal reserve function and that protein meal challenge is a sensitive test for detecting changes in renal function.
Introduction
Single high protein meal has been demonstrated to increase the renal blood flow (RBF) in animals. '1, 2 Prolonged dietary protein manipulation and intravenous amino acid infusion has also been shown to change glomerular filtration rate (GFR) and RBF in man,3'4 and recently there has been increasing interest in the changes in GFR and RBF with a single high protein meal. 5 We have used these changes induced by protein meal to assess the effect of antihypertensive treatment with nifedipine and mefruside on renal function and renal homeostasis.
Patients and method
Seven patients (age 35-60) with essential hypertension were studied. All had diastolic blood pressure of more than 100mmHg at two separate clinics before entering this trial and had normal blood urea, electrolytes and haemoglobin. None of the patients had oedema or ascites. Patients with prostatism or bladder dysfunction were excluded from the study. The patients were fully informed about the nature and purpose of the study which was approved by the Lothian ethics committee.
All the patients were maintained on their normal diet for the duration of the trial. Dietary protein was assessed by dietary history, which showed an average protein content of 60g/day. Following an overnight fast they were admitted to hospital at 09.30 h. They were kept in the recumbent position throughout the study. At 10.00 h an infusion of inulin and para-amino hippurate (PAH) in 500 ml 5% dextrose was commenced following a bolus injection. The patients were then encouraged to drink water to maintain good urinary output (range 130 to 480 ml/hour). At 12.00 h a meal containing 30 g of animal protein (roast beef sandwich) was served. Inulin and PAH clearances were measured for one hour before and one hour immediately after the meal using hourly blood samples and spontaneously passed urine volume, urine concentrations and plasma concentrations.6'7 Glomerular filtration rate (GFR) was defined as inulin clearance, and effective renal plasma flow (ERPF) was calculated from PAH clearance. GFR and ERPF were measured after 3 weeks on placebo and repeated after 6 weeks' treatment with nifedipine retard 20mg twice daily and mefruside (a thiazide diuretic) 25mg/day. GFR and ERPF are expressed in ml/min/1.73 m2 of body surface area.
The results are expressed as mean + standard error of mean (s.e.m.). The two tailed t-test is used for comparison of paired data.
Results
There was a significant reduction in supine systolic blood pressure following 6 weeks' treatment with nifedipine and mefruside from 178 + 4.2 mmHg to 148+5.5mmHg (P<0.001). There was a similar reduction in diastolic blood pressure from 105+3.6mmHg to 89+3.7mmHg (P<0.001). The patient weights remained stable throughout the trial (80+4.7kg). The blood urea, electrolytes and haemoglobin remained unchanged during the period of the trial.
Fasting GFR on placebo treatment ranged from 29 to 112ml/min/1.73m2 (mean 60.9 + 10.9). Following the protein meal there was a significant rise in GFR to 78.7+9.3ml/min/1.73m2 (P<0.01). There was also a significant rise in ERPF from 277+63.1 (range 30 to 583) to 451+90.7ml/min/ 1.73 m2; P < 0.05) (Figure 1 14 The mechanism underlying these changes is not fully understood, but it is possibly related to a circulating effector.
We have looked at the combination therapy with nifedipine and a diuretic, as in practice we have often used this combination to achieve satisfactory blood pressure control in hypertensive patients. 
